Holen Sie sich die Stockscreener-App
0.7405
2.72%
0.0196
Handel nachbörslich:
.74
-0.0005
-0.07%
Schlusskurs vom Vortag:
$0.7209
Offen:
$0.71
24-Stunden-Volumen:
1.76M
Relative Volume:
0.40
Marktkapitalisierung:
$218.27M
Einnahmen:
$55.87M
Nettoeinkommen (Verlust:
$-77.60M
KGV:
-2.076
EPS:
-0.3567
Netto-Cashflow:
$-79.46M
1W Leistung:
+10.01%
1M Leistung:
-0.27%
6M Leistung:
-52.23%
1J Leistung:
+4.72%
1-Tages-Spanne:
$0.682
$0.7499
1-Wochen-Bereich:
$0.66
$0.7499
52-Wochen-Spanne:
$0.483
$3.0699
Invivyd Inc Stock (IVVD) Company Profile
Firmenname
Invivyd Inc
Sektor
Branche
Telefon
(781) 819-0080
Adresse
209 CHURCH STREET, NEW HAVEN
Compare IVVD vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
0.7405 | 212.49M | 55.87M | -77.60M | -79.46M | -0.3567 |
VRTX
Vertex Pharmaceuticals Inc
|
515.55 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.93 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
987.84 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
212.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.51 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-22 | Eingeleitet | BTIG Research | Buy |
| 2025-11-25 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-10-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-04-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-03-26 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Invivyd Inc Aktie (IVVD) Neueste Nachrichten
In vivodyne (NASDAQ: IVVD) holder plans 40,800-share sale - Stock Titan
Invivyd (NASDAQ: IVVD) insider plans 40,800-share sale - Stock Titan
Invivyd (NASDAQ: IVVD) holder to sell 40,800 shares after RSU vest - Stock Titan
Invivyd (NASDAQ: IVVD) holder plans sale of RSU-based shares - Stock Titan
Invivyd (NASDAQ: IVVD) holder to sell 37,741 shares via Morgan Stanley - Stock Titan
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
Invivyd (IVVD) sees 6.3% ownership reported by Perceptive Advisors group - Stock Titan
Invivyd (IVVD): BVF-led group discloses 29.6M shares, 9.99% beneficial stake - Stock Titan
Invivyd earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Invivyd (NASDAQ:IVVD) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Invivyd, Inc. Q2 2026: Revenue $14.29M, EPS $(0.14) — 10-Q Summary - TradingView
Invivyd (IVVD) widens loss, warns on going concern as cash falls to $160M - Stock Titan
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
BRIEF-Invivyd Q2 EPS USD -0.14 - TradingView
IVVD Q2'26 Earnings: revenue estimate is 14.40M USD - TradingView
Invivyd Insider Purchases Yet To Pay Off Regardless Of Recent Strength - Moomoo
Invivyd, Inc. expected to post a loss of 11 cents a shareEarnings Preview - TradingView
Invivyd Inc (IVVD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Invivyd Inc (IVVD) Stock News Today - TradingKey
Invivyd Inc (IVVD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Invivyd (IVVD) to Release Earnings on Thursday - MarketBeat
Invivyd (IVVD) Gains 7.27% to $0.61, Testing Key Resistance After Volatile SessionInverse ETF Flow - dars.gov.et
Invivyd Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Invivyd Shareholder Action Reminder - TMX Newsfile
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - manilatimes.net
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Invivyd grants 277,500 inducement stock options to new hires at $0.54 exercise price - Bitget
Invivyd, Inc. (NASDAQ:IVVD) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Invivyd Inc (IVVD) Valuation: PE, PB & Fair Value Analysis - TradingKey
BlackRock (NYSE: BLK) discloses 5.5% beneficial stake in Invivyd (IVVD) - Stock Titan
Invivyd Inc (IVVD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Invivyd Inc (IVVD) Cash Flow - TradingKey
Invivyd Market Sentiment - Benzinga España
IVVD|Invivyd Inc|Price:0.604|Chg%:-0.007 - TradingKey
Invivyd Inc (IVVD) Balance Sheet - TradingKey
Invivyd Inc (IVVD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Invivyd Inc (IVVD) Income Statement - TradingKey
Invivyd Inc (IVVD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IVVD|Invivyd Inc|Price:0.659|Chg%:+0.055 - TradingKey
Invivyd Inc (IVVD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IVVD|Invivyd Inc|Price:0.611|Chg%:+0.002 - TradingKey
IVVD|Invivyd Inc|Price:0.728|Chg%:+0.041 - TradingKey
Invivyd Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Invivyd Inc (IVVD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IVVD stock trades around recent lows as Invivyd highlights COVID-19 antibody pipeline - Ad-hoc-news.de
Invivyd Inc. (IVVD) Slides 5.76% as Resistance Holds Near $0.78Moving Average Ribbon - dars.gov.et
Invivyd stock trades around recent lows as investors weigh antibody revenue outlook - Ad-hoc-news.de
Invivyd Inc. (IVVD) Q1 2026 Earnings: EPS Falls Short of Estimates; Stock Edges Up Despite Wider LossEPS Surprise History - dars.gov.et
Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK) - The Globe and Mail
Invivyd Inc updates investors on its antiviral pipeline as Nasdaq-listed biotech advances - AD HOC NEWS
Finanzdaten der Invivyd Inc-Aktie (IVVD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Invivyd Inc-Aktie (IVVD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Allen Robert D. III | Chief Scientific Officer |
Feb 17 '26 |
Sale |
1.54 |
18,189 |
28,004 |
133,879 |
| Green Julie | Chief Human Resources Officer |
Feb 18 '26 |
Sale |
1.58 |
20,964 |
33,077 |
107,717 |
| Green Julie | Chief Human Resources Officer |
Feb 17 '26 |
Sale |
1.54 |
19,663 |
30,273 |
128,681 |
| Duke William E. | Chief Financial Officer |
Feb 18 '26 |
Sale |
1.58 |
20,964 |
33,077 |
107,717 |
| Duke William E. | Chief Financial Officer |
Feb 17 '26 |
Sale |
1.54 |
19,663 |
30,273 |
128,681 |
| Lee Timothy Edward | Chief Commercial Officer |
Feb 18 '26 |
Sale |
1.58 |
20,964 |
33,077 |
117,717 |
| Lee Timothy Edward | Chief Commercial Officer |
Feb 17 '26 |
Sale |
1.54 |
19,663 |
30,273 |
138,681 |
| Andersen Jill | Chief Legal Officer, Secretary |
Feb 18 '26 |
Sale |
1.58 |
34,939 |
55,127 |
181,736 |
| Andersen Jill | Chief Legal Officer, Secretary |
Feb 17 '26 |
Sale |
1.54 |
32,771 |
50,454 |
216,675 |
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):